Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie has recently completed a Phase 3b clinical ...

AbbVie and Genmab’s epcoritamab has shown promise as part of a combination treatment for relapsed or refractory follicular ...

In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...

New research suggests many Australians may be using home blood pressure monitors with cuffs that don’t fit their arm properly. This can lead to inaccurate readings.

A large trial in a primary care setting found daily emollient use to be safe, feasible, and effective in reducing atopic ...

On May 12, Trump signed an executive order stating that U.S. consumers are being overcharged for prescription drugs and that ...

UChicago Medicine is launching a national cancer network to bring its academic medicine expertise to other communities in the ...

ICICI Securities is bearish on Glenmark Pharmaceuticals has recommended sell rating on the stock with a target price of Rs 1570 in its research report dated August 19, 2025.

Sales of rhCollagen and bioinks primed for augmentation following new U.S.-based commercial executive hire -- Raised $3.6 million in registered direct offering in second quarter - REHOVOT ...

Additionally, a study published in July 2025 examined the use of methotrexate as first-line treatment for pulmonary ...